Article ; Online: A drug delivery strategy emerges that has the potential to transform cancer therapy.
2024 Volume 29, Issue 4, Page(s) 103923
Abstract: The shortcomings of current approaches to treating cancer are driving the need for novel, innovative strategies that reduce the toxicity associated with chemotherapy and improve on the limited efficacy of immunotherapy. We believe that dual delivery of ... ...
Abstract | The shortcomings of current approaches to treating cancer are driving the need for novel, innovative strategies that reduce the toxicity associated with chemotherapy and improve on the limited efficacy of immunotherapy. We believe that dual delivery of small interfering RNA (siRNA) via a suitable delivery system, with or without a relevant, additional, small-molecule therapeutic agent, will herald new era of treatment efficiency in cancer. |
---|---|
MeSH term(s) | Humans ; Nanoparticles ; Drug Delivery Systems ; Neoplasms/therapy ; RNA, Small Interfering ; Immunotherapy |
Chemical Substances | RNA, Small Interfering |
Language | English |
Publishing date | 2024-02-23 |
Publishing country | England |
Document type | Editorial |
ZDB-ID | 1324988-5 |
ISSN | 1878-5832 ; 1359-6446 |
ISSN (online) | 1878-5832 |
ISSN | 1359-6446 |
DOI | 10.1016/j.drudis.2024.103923 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4725: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.